HuGE Literature Finder
Records
1
-
30
| Characterization of the HER2 status in BRCA-mutated breast cancer: a single institutional series and systematic review with pooled analysis. ESMO open 2022 Jul 7 (4): 100531. Tomasello G, Gambini D, Petrelli F, Azzollini J, Arcanà C, Ghidini M, Peissel B, Manoukian S, Garrone |
| Mutational spectrum of BRCA1/2 genes in Moroccan patients with hereditary breast and/or ovarian cancer, and review of BRCA mutations in the MENA region. Breast cancer research and treatment 2022 Jul 194 (1): 187-198. Elalaoui Siham Chafai, Laarabi Fatima Zohra, Afif Lamiae, Lyahyai Jaber, Ratbi Ilham, Jaouad Imane Cherkaoui, Doubaj Yassamine, Sahli Meryem, Ouhenach Mouna, Sefiani Abdelaz |
| BRCA1/2 pathogenetic variant carriers and reproductive decisions: Gender differences and factors associated with the choice of preimplantation genetic diagnosis (PGD) and prenatal diagnosis (PND). Journal of assisted reproduction and genetics 2022 Jun . Lombardi Lucia, Trumello Carmen, Stuppia Liborio, Antonucci Ivana, Brandão Tânia, Babore Alessand |
| Breast Cancer with Low Recurrence Score on Oncotype DX Oncology and therapy 2022 Jun . Zarbiv Yonaton, Wygoda Yael Berner, Grinshpun Albert, Hamburger Tamar, Sella Tamar, Breuer Shani, Maimon Ofra, Rottenberg Yakir, Peretz Tamar, Kadouri Lu |
| Risk of pancreatic ductal adenocarcinoma associated with carriage of BRCA1 and/or BRCA2 mutation: A systematic review and meta-analysis. Journal of surgical oncology 2022 Jun . McGarry Jennifer L, Creavin Ben, Kelly Michael E, Gallagher Tom |
| The Impact of BRCA1- and BRCA2 Mutations on Ovarian Reserve Status. Reproductive sciences (Thousand Oaks, Calif.) 2022 Jun . C E Drechsel Katja, C van Tilborg Theodora, J C Eijkemans Marinus, G W M Lentjes Eef, Irene Homminga, Mariette Goddijn, J T van Golde Ron, Willem Verpoest, D Lichtenbelt Klaske, J M Broekmans Frank, M E Bos An |
| The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases. The Prostate 2022 Jun . Liu Alex J, Kosiorek Heidi E, Ueberroth Benjamin E, Jaeger Ellen, Ledet Elisa, Kendi Ayse T, Tzou Katherine, Quevedo Fernando, Choo Richard, Moore Cassandra N, Ho Thai H, Singh Parminder, Keole Sameer R, Wong William W, Sartor Oliver, Bryce Alan |
| Endometrial Cancer and BRCA Mutations: A Systematic Review. Journal of clinical medicine 2022 May 11 (11): . Gasparri Maria Luisa, Bellaminutti Serena, Farooqi Ammad Ahmad, Cuccu Ilaria, Di Donato Violante, Papadia Andr |
| The effect of PARP inhibitors in homologous recombination proficient ovarian cancer: meta-analysis. Journal of chemotherapy (Florence, Italy) 2022 May 1-8. Skelin Marko, Šar?evi? David, Lešin Ga?ina Dina, Mucalo Iva, Dilber Ivo, Javor Eug |
| Concurrent BRAFV600E and BRCA Mutations in MSS Metastatic Colorectal Cancer: Prevalence and Case Series of mCRC patients with prolonged OS. Cancer treatment and research communications 2022 Apr 32 100569. Cannon Timothy Lewis, Randall Jamie N, Sokol Ethan S, Alexander Sonja M, Wadlow Raymond C, Winer Arthur A, Barnett Daniel M, Rayes Danny L, Nimeiri Halla S, McGregor Kimberly |
| Does breast-conserving surgery with radiotherapy in BRCA-mutation carriers significantly increase ipsilateral breast tumor recurrence? A systematic review and meta-analysis. Breast cancer (Tokyo, Japan) 2022 Feb . Nara Miyako, Ishihara Sakiko, Kitano Atsuko, Tamura Nobuko, Aruga Tomoyuki, Kobayashi Daiki, Nakamura Seigo, Yamauchi Hide |
| Identification and characterization of three Siglec15-related immune and prognostic subtypes of breast-invasive cancer. International immunopharmacology 2022 Feb 106 108561. Cao Xi, Zhou Yidong, Mao Feng, Lin Yan, Zhou Xingtong, Sun Qia |
| Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients. Breast cancer research and treatment 2022 Feb . Lin Po-Han, Chen Shin-Cheh, Tseng Ling-Ming, Chang King-Jen, Huang Ai-Chu, Cheng Kuo-Chih, Yang Karen, Wu Hui-Chen, Chao Tsu-Yi, Chang Yuan-Ching, Lin Peng-Chan, Kuo Wen-Hung, Kuo Wen-Lin, Lin Ching-Hung, Chen Huo-Mu, Yeh Dah-Cherng, Liu Liang-Chih, Liu Chun-Yu, Wang Ming-Yang, Lo Chiao, Lu Yen-Shen, Huang Chiun-She |
| Hyperthermic intraperitoneal chemotherapy (HIPEC) after primary debulking surgery in advanced epithelial ovarian cancer: Is BRCA mutational status making the difference? Cancer treatment and research communications 2022 Jan 31 100518. Ghirardi Valentina, De Felice Francesca, D'Indinosante Marco, Bernardini Federica, Giudice Maria Teresa, Fagotti Anna, Scambia Giovan |
| Breast Cancer Prognosis Prediction and Immune Pathway Molecular Analysis Based on Mitochondria-Related Genes. Genetics research 2022 2022 2249909. Luo Weixu, Han Yuanshan, Li Xin, Liu Zhuo, Meng Pan, Wang Yuho |
| Comparative Efficacy and Safety of Poly (ADP-Ribose) Polymerase Inhibitors in Patients With Ovarian Cancer: A Systematic Review and Network Meta-Analysis. Frontiers in oncology 2022 12 815265. Luo Jing, Ou Shunlong, Wei Hua, Qin Xiaoli, Jiang Qi |
| Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation. Gynecologic oncology 2022 01 . Xia Yue Yin, Gronwald Jacek, Karlan Beth, Lubinski Jan, McCuaig Jeanna M, Brooks Jennifer, Moller Pal, Eisen Andrea, Sun Sophie, Senter Leigha, Bordeleau Louise, Neuhausen Susan L, Singer Christian F, Tung Nadine, Foulkes William D, Sun Ping, Narod Steven A, Kotsopoulos Joanne, |
| Dermatological and Dermoscopic Baselines in BRCA Mutation Carriers. Frontiers in medicine 2022 9 863468. Paolino Giovanni, Pampena Riccardo, Di Nicola Matteo Riccardo, Longo Caterina, Rognone Alessia, Zambelli Stefania, Bianchini Giampaolo, Mercuri Santo Raffae |
| Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population. BMC medical genomics 2022 07 15 (1): 146. Huang Qingfeng, Zhou Yang, Wang Bowen, Zhao Yi, Zhang Fengxia, Ding Bow |
| Concordance of BRCA mutation detection in tumor versus blood, and frequency of bi-allelic loss of BRCA in tumors from patients in the phase III SOLO2 trial. Gynecologic oncology 2021 Nov . Hodgson Darren R, Brown Jessica S, Dearden Simon P, Lai Zhongwu, Elks Cathy E, Milenkova Tsveta, Dougherty Brian A, Lanchbury Jerry S, Perry Michael, Timms Kirsten M, Harrington Elizabeth A, Barrett J Carl, Leary Alexandra, Pujade-Lauraine Er |
| Impact of BRCA mutations and hormone receptor status on reproductive potential in breast cancer patients undergoing fertility preservation. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2021 Nov 1-4. Kim Sung Woo, Kim Tae Hee, Han Ji Yeon, Kim Seul Ki, Lee Jung Ryeol, Jee Ung Chul, Suh Chang Suk, Kim Seok Hy |
| Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness. NPJ breast cancer 2021 Nov 7 (1): 142. Metzger-Filho Otto, Collier Katharine, Asad Sarah, Ansell Peter J, Watson Mark, Bae Junu, Cherian Mathew, O'Shaughnessy Joyce, Untch Michael, Rugo Hope S, Huober Jens B, Golshan Mehra, Sikov William M, von Minckwitz Gunter, Rastogi Priya, Li Lang, Cheng Lijun, Maag David, Wolmark Norman, Denkert Carsten, Symmans W Fraser, Geyer Charles E, Loibl Sibylle, Stover Daniel |
| Clinicopathological features and BRCA1 and BRCA2 mutation status in a prospective cohort of young women with breast cancer. British journal of cancer 2021 Oct . Guzmán-Arocho Yaileen D, Rosenberg Shoshana M, Garber Judy E, Vardeh Hilde, Poorvu Philip D, Ruddy Kathryn J, Kirkner Gregory, Snow Craig, Tamimi Rulla M, Peppercorn Jeffrey, Schapira Lidia, Borges Virginia F, Come Steven E, Brachtel Elena F, Marotti Jonathan D, Warner Ellen, Partridge Ann H, Collins Laura |
| Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center. Annals of surgical oncology 2021 Oct . Mittal Abhenil, Deo S V S, Gogia Ajay, Batra Atul, Kumar Akash, Bhoriwal Sandeep, Deb Koushik Sinha, Dhamija Ekta, Thulkar Sanjay, Ramprasad V L, Olopade Olufunmilayo, Pramanik Ra |
| Association of RAD51 with Homologous Recombination Deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial. Annals of oncology : official journal of the European Society for Medical Oncology 2021 Sep . Llop-Guevara A, Loibl S, Villacampa G, Vladimirova V, Schneeweiss A, Karn T, Zahm D-M, Herencia-Ropero A, Jank P, van Mackelenbergh M, Fasching P A, Marmé F, Stickeler E, Schem C, Dienstmann R, Florian S, Nekljudova V, Balmaña J, Hahnen E, Denkert C, Serra |
| Correction to: Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study. Breast cancer (Tokyo, Japan) 2021 Sep . Koh Su-Jin, Ohsumi Shozo, Takahashi Masato, Fukuma Eisuke, Jung Kyung Hae, Ishida Takanori, Dai Ming-Shen, Chang Chuan-Hsun, Dalvi Tapashi, Walker Graham, Bennett James, O'Shaughnessy Joyce, Balmaña Judi |
| Ovarian reserve of women with and without BRCA pathogenic variants: A systematic review and meta-analysis. Breast (Edinburgh, Scotland) 2021 Sep 60 155-162. Gasparri Maria Luisa, Di Micco Rosa, Zuber Veronica, Taghavi Katayoun, Bianchini Giampaolo, Bellaminutti Serena, Meani Francesco, Graffeo Rossella, Candiani Massimo, Mueller Michael D, Papadia Andrea, Gentilini Oreste |
| PARP inhibitors decrease response to subsequent platinum-based chemotherapy in patients with BRCA mutated ovarian cancer. Anti-cancer drugs 2021 Sep . Rose Peter G, Yao Meng, Chambers Laura M, Mahdi Haider, DeBernardo Robert, Michener Chad M, AlHilli Miriam, Ricci Stephanie, Vargas Rober |
| The prevalence of ataxia telangiectasia mutated (ATM) variants in patients with breast cancer patients: a systematic review and meta-analysis. Cancer cell international 2021 Sep 21 (1): 474. Moslemi Masoumeh, Vafaei Maryam, Khani Pouria, Soheili Marzieh, Nedaeinia Reza, Manian Mostafa, Moradi Yousef, Sohrabi Ehs |
| Effects of Neoadjuvant Chemotherapy in Ovarian Cancer Patients With Different Germline BRCA1/2 Mutational Status: A Retrospective Cohort Study. Frontiers in oncology 2021 11 810099. Fu Mengdi, Jin Chengjuan, Feng Shuai, Jia Zongyang, Nie Lekai, Zhang Yang, Peng Jin, Wang Xia, Bu Hualei, Kong Beih |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 10, 2022
- Content source: